The Role of Criminal Justice Pressures on Ecstasy Drug Markets

Sheigla B. Murphy, Institute for Scientific Analysis
Paloma Sales, Institute for Scientific Analysis
Micheline Duterte, Institute for Scientific Analysis
Camille Jacinto, Institute for Scientific Analysis

As we proceed into the new millennium, the national focus has shifted to a relatively new drug, MDMA (3,4-methylenedioxymethamphetamine), commonly known as Ecstasy. The escalating use of Ecstasy portends an increased demand for it, leading perhaps to the convergence of drug markets (suppliers adding a new drug to their product line) or the emergence of new dealer networks. To date very little is known about Ecstasy distribution. In this presentation, we will present preliminary findings from our National Institute on Justice funded project entitled: "A Qualitative Study of Ecstasy Sellers" (July 2002-June 2004). Our investigation is focused on the following domains: individuals' history of drug use and sales, sellers' lifestyle issues, marketplace characteristics (including pricing, quality control, levels and settings of sales), customers' demographics, buyer and seller relationships, descriptions of distribution hierarchies, and from the sellers' perspective, the role of prevention efforts and law enforcement practices on all of the above.

(Return to Program Resources)

Updated 05/20/2006